WHO Expert Committee on Specifications for Pharmaceutical Preparations - WHO Technical Report Series, No. 885 - Thirty-fifth Report
(1999; 168 pages) [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoWHO Expert Committee on Specifications for Pharmaceutical Preparations
Ver el documento1. Introduction
Abrir esta carpeta y ver su contenido2. The international pharmacopoeia and related issues
Abrir esta carpeta y ver su contenido3. International Chemical Reference Substances and Infrared Reference Spectra
Abrir esta carpeta y ver su contenido4. Quality control - national laboratories
Abrir esta carpeta y ver su contenido5. Good manufacturing practices
Abrir esta carpeta y ver su contenido6. Quality systems and inspection
Abrir esta carpeta y ver su contenido7. Other quality assurance topics
Abrir esta carpeta y ver su contenido8. Nomenclature and terminology
Abrir esta carpeta y ver su contenido9. Legal aspects of pharmaceuticals
Abrir esta carpeta y ver su contenido10. Regulatory issues
Abrir esta carpeta y ver su contenido11. Training activities
Ver el documento12. Pharmaceuticals contaminated with diethylene glycol
Ver el documentoAcknowledgements
Ver el documentoReferences
Ver el documentoAnnex 1. List of available International Chemical Reference Substances1
Ver el documentoAnnex 2. List of available International Infrared Reference Spectra1
Abrir esta carpeta y ver su contenidoAnnex 3. General guidelines for the establishment, maintenance and distribution of chemical reference substances
Abrir esta carpeta y ver su contenidoAnnex 4. Good manufacturing practices: authorized person - role, functions and training
Abrir esta carpeta y ver su contenidoAnnex 5. Good manufacturing practices: supplementary guidelines for the manufacture of pharmaceutical excipients
Abrir esta carpeta y ver su contenidoAnnex 6. Guidelines for inspection of drug distribution channels
Ver el documentoAnnex 7. Good pharmacy practice in community and hospital pharmacy settings
Cerrar esta carpetaAnnex 8. National drug regulatory legislation: guiding principles for small drug regulatory authorities
Ver el documentoIntroduction
Ver el documentoDrafting national legislation: points for consideration
Ver el documentoDefining the scope of the marketing authorization procedure for medicinal products
Cerrar esta carpetaExample of a legislative scheme for regulating medicinal products
Ver el documentoGeneral considerations
Ver el documentoPotential value of the scheme
Cerrar esta carpetaModel legislative text and commentary
Ver el documentoPart A. Administration
Ver el documentoPart B. Provisional registration/marketing authorization and inventory of medicinal products
Ver el documentoPart C. Screening of products and issuance of product licences/authorizations
Ver el documentoPart D. Other activities requiring authorization/licensing
Ver el documentoPart E. General provisions
Ver el documentoPart F. Interpretation
Ver el documentoReferences
Ver el documentoSelected bibliography
Ver el documentoAppendix 1. Provisional legislative scheme for registration of pharmacy personnel
Ver el documentoAppendix 2. Guidelines, documents and other regulatory instruments established by WHO to support drug regulatory authorities
Abrir esta carpeta y ver su contenidoAnnex 9. Provisional guidelines for developing training programmes: inspection and examination of counterfeit pharmaceuticals
Ver el documentoWorld Health Organization Technical Report Series
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack Cover
 
Part D. Other activities requiring authorization/licensing

13.1 On or after such date as is specified in a notice published in the gazette or in any official publication as may be specified in the regulation, a person carrying on a business of manufacturing, importing, exporting, compounding, storing, dispensing, selling, supplying or otherwise distributing medicinal products must possess a valid authorization/licence in order to carry out that activity.

13.2 The licensing authority shall maintain a register of pharmacies. An application for registration of pharmacy premises under this section must be made in accordance with regulations issued by the minister.

13.3 The particulars to be furnished by applicants for an authorization/licence, their qualifications and suitability, and the terms, requirements and conditions under which such authorizations/licences may be granted, shall be specified by the drug regulatory authority in regulations made under the Law.

13.4 Any person aggrieved by a decision of the drug regulatory authority may appeal, within two weeks of the notification of the decision of the drug regulatory authority, to the minister/authority.

13.5 On receipt of an appeal the minister/authority may decide whether or not the drug regulatory authority should be directed to rescind, suspend, vary, modify, reconfirm or reconsider the order in respect of which the appeal has been lodged.

Parts B and C were concerned with medicinal products, whereas Part D deals with individuals, companies, firms, hospital clinics or dispensaries, pharmacies, etc., who need a licence/authorization to engage in various activities.

 

There is a right of appeal to the minister/authority against any decision of the drug regulatory authority. Provision for administrative relief in the first instance is important, as litigation generally tends to be protracted, costly and inconvenient for all parties concerned.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013